The leading global voice
We play a major role in bringing the CV community together to drive transformational change.
Together we are stronger
By 2025, our aim is to reduce premature deaths from CVD by at least 25%.
Join the fight
Become a WHF member and help us to build global commitment to address cardiovascular health at the policy level.
We convene and connect our members
To share science, best practice and resources, acting as a global thought leader and catalyst for positive change.
Celebrate World Heart Day
The biggest global awareness-raising campaign for CVD.
Attend the Congress
Join world leaders in heart health, share ideas, network with specialists.
Advocating for heart health
We lead the global advocacy effort for action to prevent, control and reduce the global burden of CVD.
All our programmes and partnerships are aimed at creating awareness of CVD as a priority issue across the globe.
Find out more about our and our members’ work around the world.
Explore everything from toolkits, videos and infographics, to policy reports, factsheets and more.
Find out more about our and our members' work around the world.
On 6 March, WHO Director-General Dr Tedros Adhanom Ghebreyesus announced the details of far-reaching organisational reform and the reshuffling of the WHO’s top leadership. The new structure aims to reduce “silos” within the organisation and to promote “one WHO”. For example, there will only be one Deputy Director-General (DDG) reporting to Dr Tedros: Zsuzsanna Jakab, former RD of WHO Europe. The new Assistant Directors-General (ADGs) will all report to the DDG, with the exception of the UHC and Life Course Programme led by Australian Executive Director Peter Salama, who will be reporting jointly to the DDG and Dr Tedros. The reform also aims to align WHO’s processes and structures with the “triple billion” targets and the Sustainable Development Goals.
The new programme structure is not yet clear to many; nor are the budgetary priorities. What we can report based on meetings held at WHO on 8 March is that the new changes seem conducive to a more holistic working approach within the organisation. Other notable changes include: reinforcing WHO’s normative, standard-setting work, supported by a new Division of the Chief Scientist and improved career opportunities for scientists; harnessing the power of digital health and innovation by supporting countries to assess, integrate, regulate and maximize the opportunities of digital technologies and artificial intelligence; making WHO more relevant at the country level with the support of a new Division of Data, Analytics and Delivery; and reinforcing a corporate approach to resource mobilization aligned with strategic objectives and driving new fundraising initiatives to diversify WHO’s funding base and strengthen its long-term financial stability. The WHF Advocacy Team will continue to monitor the effects of the reform and share updated assessments with our Members.
Report from WHF-IDF event on CVD in people with diabetes now available
NOACs and fixed-dose combination antihypertensive medications added to WHO Essential Medicines List
Air pollution and cardiovascular disease: a window of opportunity